Amneal Pharmaceuticals, Inc. (AMRX)
14.82
+0.20
(+1.33%)
USD |
NASDAQ |
Feb 13, 16:00
14.82
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Shareholders Equity (Quarterly) : -109.46M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 631.90M |
| Pfizer Inc. | -- |
| Apellis Pharmaceuticals, Inc. | 401.17M |
| Nektar Therapeutics | 85.09M |
| Innoviva, Inc. | 1.010B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.600B |
| Total Liabilities (Quarterly) | 3.642B |
| Debt to Equity Ratio | -24.54 |
| Current Ratio | 2.132 |
| Net Debt Paydown Yield | 0.25% |